Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,182.00    0.00 (0.00%)
Bid:
1,170.00
Ask:
1,200.00
Spread: 30.00 (2.564%)
Market Cap: £541.66m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Director/PDMR Shareholding

15 Aug 2017 10:29

RNS Number : 0354O
Cohort PLC
15 August 2017
 

15 August 2017

AIM: CHRT

COHORT PLC (the "Company")

Director Share Awards and Shareholdings

Cohort plc (the "Company") wishes to notify the following changes in the interests of directors of the Company in ordinary shares of 10 pence in relation to share awards and share options.

 

Grant and Transfer of Share Awards

On 10 August 2017 share awards pursuant to the 2013 Restricted Share Scheme established on 30 July 2013 (the "Restricted Share Scheme") were granted to directors of the Company for nil consideration. Also on 10 August, shares that had vested on 10 August in accordance with the rules of the Restricted Share Scheme were transferred to the directors of the Company (the "Transfers"). The following table sets out the details of the Grant and Transfers:

 

Director

Number of sharesunder this award

Number of shares vested and transferred on 10 August 2017

Total number of unvested shares under the Restricted Share Scheme following Grant and Transfers

AS Thomis

18,254

15,028

22,321

SR Walther

14,286

11,979

17,599

 

Full beneficial ownership of Restricted Shares (including voting and dividend rights) will transfer to the recipients in stages over a three-year period from the date of grant. Recipients may only sell Restricted Shares with the approval of the Chairman of the Remuneration & Appointments Committee while they remain in employment with the Company. Further details regarding the Restricted Shares can be found in the Company's Annual Report and Accounts 2017.

 

Director Shareholdings

Following completion of the transactions detailed above on 10 August 2017, the interests of Mr Thomis and Mr Walther and their connected persons in the shares of Cohort plc will be as follows:

 

Director

Ordinary shares*

% of the total issued share capital

AS Thomis

111,521

0.27

SR Walther

100,659

0.25

*Not including unvested shares under the Restricted Share Scheme

 

Ends

For further information, please contact:

Cohort plc

 

0118 909 0390

Andrew Thomis, Chief ExecutiveSimon Walther, Finance Director

 

 

 

 

 

Investec Bank plc

 

020 7597 5970

Keith Anderson / Daniel Adams

 

 

 

 

 

MHP Communications Limited

 

020 3128 8100

Reg Hoare / Ollie Hoare

 

 

 

NOTES TO EDITORS

Cohort is the parent company of four innovative, agile and responsive businesses based in the UK and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

MASS is a specialist defence and technology business, focused on electronic warfare, information systems and cyber security.

www.mass.co.uk

 

MCL is an expert in the sourcing, design, integration and support of communications and surveillance technology for the defence and security markets.

www.marlboroughcomms.com

 

SEA is an advanced electronic systems and software house operating in the defence, transport and offshore energy markets.

www.sea.co.uk

 

EID designs and manufactures advanced communications systems for the defence and security markets.

www.eid.pt

 

Cohort was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 800 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Devon, Lincolnshire, Somerset, Surrey, Scotland and Portugal.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGCGDIIDBBGRU
Date   Source Headline
16th Sep 20245:34 pmRNSHolding(s) in Company
2nd Sep 20245:08 pmRNSTotal Voting Rights
2nd Sep 202411:32 amRNSHolding(s) in Company
27th Aug 20245:54 pmRNSBlock listing six monthly return
21st Aug 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Aug 20243:48 pmRNSDirector/PDMR Shareholding
16th Aug 202412:10 pmRNSHolding(s) in Company
12th Aug 20244:22 pmRNSDirector/PDMR Shareholding
2nd Aug 20242:30 pmRNSDirector/PDMR Shareholding
1st Aug 202411:43 amRNSTotal Voting Rights
29th Jul 20249:45 amRNSDirector/PDMR Shareholding
23rd Jul 20245:04 pmRNSDirector/PDMR Shareholding
17th Jul 20247:01 amRNSContract win
17th Jul 20247:00 amRNSFinal Results
15th Jul 20247:00 amRNSContract Award
11th Jul 20247:00 amRNSNotice of Results
1st Jul 20249:33 amRNSTotal Voting Rights
5th Jun 202410:59 amRNSEBT Purchase of Shares
31st May 20243:17 pmRNSTotal Voting Rights
23rd May 20241:30 pmRNSEBT Purchase of Shares
23rd May 20247:00 amRNSFull Year Trading Update
20th May 20244:01 pmRNSEBT Purchase of Shares
14th May 20242:10 pmRNSEBT Purchase of Shares
7th May 20245:24 pmRNSEBT Purchase of Shares
3rd May 202411:44 amRNSDirector/PDMR Shareholding
1st May 20245:17 pmRNSDirector/PDMR Shareholding
1st May 20245:11 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSBlock Listing Application
30th Apr 20247:00 amRNSSite visit to SEA
15th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20242:19 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:19 pmRNSBlock Listing Six Monthly Return
2nd Apr 20243:17 pmRNSTotal Voting Rights
28th Mar 20242:06 pmRNSHolding(s) in Company
27th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSContract Win
19th Mar 20249:43 amRNSContract win
13th Mar 202410:49 amRNSDirector/PDMR Shareholding
1st Mar 20247:00 amRNSTotal Voting Rights
26th Feb 20244:28 pmRNSBlock listing six monthly return
16th Feb 202412:38 pmRNSDirector/PDMR Shareholding
1st Feb 202410:02 amRNSTotal Voting Rights
29th Jan 20247:00 amRNSContract Win
17th Jan 20243:25 pmRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSInterim Report 2023
2nd Jan 202412:05 pmRNSTotal Voting Rights
22nd Dec 202312:07 pmRNSHolding(s) in Company
13th Dec 20237:01 amRNSDirectorate Change
13th Dec 20237:00 amRNSHalf Year Results
7th Dec 20237:00 amRNSEquity Development Presentation on 13 December

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.